Daniyell Thomason

· Builds and maintains collaborative relationships with 4 out of 15 statewide metabolic and genetic teams, enhancing communication and improving care coordination for newborns, including managing follow-up care for 989 babies diagnosed with rare genetic conditions.

· Oversees confirmed cases of four rare genetic diseases, including Spinal Muscular Atrophy (SMA), Pompe disease, Mucopolysaccharidosis type I (MPS-1), and Biotinidase deficiency, ensuring adherence to clinical best practices and regulatory standards.

· Achieves a 95% compliance rate with regulatory requirements by closely monitoring adherence and addressing deviations through proactive measures.

· Improves program efficiency by consistently monitoring and assessing project progress, leading to a 20% reduction in follow-up times and faster intervention.

Develops and delivers customized educational materials for over 500 patients, addressing diverse levels of health literacy and ensuring better understanding of complex genetic information

· Contributed to the development of clinical study policies and programs, emphasizing human subject protection, and provided analytical insights that influenced key decisions in over 20 medical device evaluations.

· Led and coordinated clinical trials from inception through completion, achieving an average patient retention rate of 95%.

· Designed and developed study protocols, case report forms (CRFs), and informed consent documents for over 30 clinical trials, ensuring adherence to trial objectives and compliance requirements.

· Managed patient recruitment and enrollment, successfully enrolling over 100 participants across multiple trials, while maintaining comprehensive and accurate patient records, including informed consent documentation.

· Coordinated all logistical aspects of clinical trials, scheduling over 500 patient visits and overseeing lab work, imaging studies, and investigational drug administration.

· Monitored patient responses and adverse events, ensuring 100% timely reporting to study teams and regulatory authorities, while maintaining meticulous study documentation for over 2,000 case report forms in compliance with Good Clinical Practice (GCP) standards.

• Established a safe environment for clients to openly discuss their thoughts, feelings, experiences, and concerns without fear of judgment or retribution
• Delivered crisis intervention services during more than 30 critical incidents, successfully deescalating high-stress situations, and linking individuals to vital resources for ongoing care and support.
• Developed and implemented personalized self-care strategies, modeling effective coping techniques that led to a 25% improvement in clients’ reported stress management and emotional regulation skills.